In healthcare compliance, billing for durable medical equipment (DME) often involves navigating clinical judgment, technical requirements, and fraud risk. Bone growth stimulators, or osteogenesis stimulators, are Class III devices that pose significant compliance challenges. They're costly, require physician oversight, and have been involved in enforcement actions related to kickbacks, template billing, and documentation fraud.
This template provides a structured approach to auditing bone growth stimulator billing practices. Use it to ensure your organization's billing reflects individualized clinical judgment rather than automated assumptions about medical necessity.
Purpose of the Template
This audit template helps you review bone growth stimulator billing for three high-risk patterns:
- Template billing: Identical documentation across patients, indicating automated decision-making instead of personalized assessment.
- Technical compliance gaps: Issues like missing modifiers, unsigned Certificates of Medical Necessity, or incorrect HCPCS codes.
- Financial relationship risks: Consulting agreements or service arrangements with referral sources that could hide kickback schemes.
The template is designed for quarterly audits but can be adapted for monthly reviews in high-volume settings or when addressing specific concerns.
Prerequisites
Before using this template, ensure you have:
- Access to billing records for HCPCS codes E0760, E0770, E0747, and E0749.
- Copies of Certificates of Medical Necessity (CMS-847 forms) for sampled claims.
- Documentation of any financial relationships with physicians prescribing bone growth stimulators.
- A statistically meaningful sample size for your volume (at least 30 claims per quarter).
You'll also need someone on your audit team who understands the clinical indications for bone growth stimulators. This person doesn't have to be a physician but should be able to identify when documentation doesn't match the billed service.
The Audit Template
Section 1: Billing Pattern Analysis
Gather all bone growth stimulator claims for the audit period. For each claim, document:
- Claim Identifier: [Internal claim number]
- Patient ID: [De-identified]
- HCPCS Code: [E0760 / E0770 / E0747 / E0749]
- Date of Service: [MM/DD/YYYY]
- Prescribing Physician: [Name or ID]
- Delivery Confirmation: [Yes / No / Pending verification]
Look for patterns:
- What percentage of patients seen by each prescribing physician receive a bone growth stimulator?
- Are the same HCPCS codes used repeatedly by the same physician, regardless of diagnosis?
- Do prescription dates align with delivery dates, or are there gaps suggesting billing before delivery?
Red flag threshold: If a physician prescribes stimulators for more than 40% of their patients, flag for clinical review. This doesn't prove fraud but warrants a closer look at whether clinical indications support that volume.
Section 2: Technical Compliance Checklist
For each sampled claim, verify:
- KF modifier present (indicates Class III device)
- Certificate of Medical Necessity (CMS-847) on file
- CMS-1500 form includes correct modifier: RR (rental), NU (purchased new), or UE (purchased used)
- Prescription signed and dated by physician
- Medical records document clinical indication for stimulator
- Delivery receipt matches date of service billed
Document any missing elements. A single missing modifier is a billing error. A pattern of missing modifiers across multiple claims suggests a process failure needing immediate correction.
Section 3: Documentation Variance Review
Pull the clinical documentation for 10 randomly selected claims. Review the physician notes, prescription language, and any supporting diagnostic information.
Consider:
- Does the documentation use identical or near-identical language across patients?
- Are diagnoses varied, or does every patient have the same indication?
- Do the notes reflect individualized clinical judgment, or do they read like a template?
What you're looking for: In one civil case, an insurer alleged that a DME supplier used "nearly identical receipts indicating the exact same type of DME prescribed for nearly all patients." That's the pattern you're screening for. If your documentation looks like it was generated by a mail-merge, you have a problem.
Section 4: Financial Relationship Audit
List all physicians who prescribed bone growth stimulators during the audit period. For each physician, document:
- Any consulting agreements, speaking fees, or service contracts your organization has with them.
- The nature of services provided under those agreements.
- Payment amounts and frequency.
- Whether compensation is tied to the volume or value of prescriptions.
Critical question: Could a reasonable observer view this financial relationship as influencing prescribing behavior? If the answer is yes, or even maybe, you need legal review before the relationship continues.
The Anti-Kickback Statute doesn't require proof of intent. A financial arrangement that seems designed to influence referrals can create liability even if everyone involved believes they're acting properly.
How to Customize It
This template assumes you're auditing a DME supplier or a provider group that prescribes bone growth stimulators. Adapt it based on your role:
If you're a manufacturer: Replace Section 4 with an audit of your sales representatives' interactions with prescribers. Review expense reports, meeting notes, and any "personal service agreements" with physician offices. One 2009 False Claims Act settlement involved a manufacturer that paid staff at physicians' offices to influence ordering decisions.
If you're an insurer or payer: Add a section that cross-references billed claims against delivery records. In one case, a DME supplier billed for devices on the same day but listed dates of service spanning several months. The government alleged the products were never delivered. Your claims data can reveal those timing gaps.
If you're a smaller operation: You may not have the volume to justify quarterly audits. In that case, audit every claim for the first six months, then move to sampling once you've confirmed your processes are sound.
Validation Steps
After completing the audit, take these actions:
Immediate: If you find evidence of template billing, missing technical requirements, or questionable financial relationships, stop the practices now. Don't wait for the full audit report. Between July 11, 2023, and November 14, 2024, one DME supplier submitted more than $1.1 million in fraudulent claims using template billing. The longer a problematic pattern runs, the larger your exposure.
Within 30 days: Present findings to your compliance committee or legal team. If you've identified billing errors, determine whether voluntary disclosure is appropriate. If you've found financial relationship concerns, get outside counsel involved.
Within 60 days: Revise your billing processes to address any gaps. If you found that modifiers were missing, update your billing software or add a manual verification step. If documentation was templated, retrain your clinical staff on the importance of individualized assessment.
Within 90 days: Re-audit a sample of claims to confirm your corrective actions worked. Compliance isn't a one-time project. It's a continuous process of identifying risk, correcting it, and validating that your corrections held.
Bone growth stimulators are just one category of DME, but they illustrate a broader principle: where reimbursement rules are complex, regulators will look closely. Patterns tell the story. Use this template to ensure your patterns tell the right one.
